← Leaderboards
Mark J. Mitton-Fry
Ohio State University
$2,212,675
Attributed
$2,212,675
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $602.3K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,212,675 · 2
By mechanism
R01$1,783,675 · 1
R21$429,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- John P Bruno$4,857,712
- Jeffrey D Parvin$10,706,494
- Ramiro Garzon$6,835,986
- Mona El Refaey$2,218,671
- Jack C. Yalowich$4,212,052
Others in their field
Other Emerging Leaders on “Innovation”
- Klaus Romero · Critical Path Institute$86,053,372
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$70,992,558
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$69,953,681
- Tony Moody · Duke University$65,625,959
- Matthew Johnson · Duke University$60,590,296
Research focus
InnovationMolecularEnzyme InhibitionInfectionMinimum Inhibitory Concentration MeasurementModificationDna Topoisomerase IvDrug Resistant BacteriaEvaluationFluoroquinolone ResistanceLeadMethicillin Resistant Staphylococcus AureusAnti-Bacterial AgentsBacteriaAlkalinityDna GyraseBindingAntimicrobial ResistanceEnzymesBiologicalCardiovascular SystemCellsDesignMulti-Drug Resistance
Grant awards (5)
Overcoming Resistance to Novel Bacterial Topoisomerase Inhibitors$590,675
R01 · FY2025 · AI · contact PI
Overcoming Resistance to Novel Bacterial Topoisomerase Inhibitors$590,675
R01 · FY2024 · AI · contact PI
Overcoming Resistance to Novel Bacterial Topoisomerase Inhibitors$602,325
R01 · FY2023 · AI · contact PI
Novel Bacterial Topoisomerase Inhibitors Targeting Gram-Negative Bacteria$195,000
R21 · FY2021 · AI · contact PI
Novel Bacterial Topoisomerase Inhibitors Targeting Gram-Negative Bacteria$234,000
R21 · FY2020 · AI · contact PI